These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29378718)

  • 21. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of clofazimine on the treatment outcomes of drug-resistant tuberculosis.
    Wang MG; Liu XM; Wu SQ; He JQ
    Microbes Infect; 2023; 25(1-2):105020. PubMed ID: 35792202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial.
    Skrahin A; Ahmed RK; Ferrara G; Rane L; Poiret T; Isaikina Y; Skrahina A; Zumla A; Maeurer MJ
    Lancet Respir Med; 2014 Feb; 2(2):108-22. PubMed ID: 24503266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensively drug resistance (XDR) tb is not always fatal.
    Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P
    Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.
    Dey T; Brigden G; Cox H; Shubber Z; Cooke G; Ford N
    J Antimicrob Chemother; 2013 Feb; 68(2):284-93. PubMed ID: 23054996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved outcomes following addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis.
    Yao G; Zhu M; Nie Q; Chen N; Tu S; Zhou Y; Xiao F; Liu Y; Li X; Chen H
    J Int Med Res; 2023 Jan; 51(1):3000605221148416. PubMed ID: 36719280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First series of patients with XDR and pre-XDR TB treated with regimens that included meropenen-clavulanate in Argentina.
    Palmero D; González Montaner P; Cufré M; García A; Vescovo M; Poggi S
    Arch Bronconeumol; 2015 Oct; 51(10):e49-52. PubMed ID: 26026689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies.
    Hwang TJ; Dotsenko S; Jafarov A; Weyer K; Falzon D; Lunte K; Nunn P; Jaramillo E; Keshavjee S; Wares DF
    BMJ Open; 2014 Jan; 4(1):e004143. PubMed ID: 24384902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India.
    Prajapati K; Mishra V; Desai M; Solanki R; Naik P
    Int J Mycobacteriol; 2017; 6(3):289-295. PubMed ID: 28776529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of linezolid treatment for extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
    Liu Y; Bao P; Wang D; Li Y; Tang L; Zhou Y; Zhao W
    Jpn J Infect Dis; 2015; 68(3):244-7. PubMed ID: 25672406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.
    He XC; Tao NN; Liu Y; Zhang XX; Li HC
    BMC Infect Dis; 2017 Aug; 17(1):555. PubMed ID: 28793873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
    Dheda K; Shean K; Zumla A; Badri M; Streicher EM; Page-Shipp L; Willcox P; John MA; Reubenson G; Govindasamy D; Wong M; Padanilam X; Dziwiecki A; van Helden PD; Siwendu S; Jarand J; Menezes CN; Burns A; Victor T; Warren R; Grobusch MP; van der Walt M; Kvasnovsky C
    Lancet; 2010 May; 375(9728):1798-807. PubMed ID: 20488525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
    Li X; Wang H; Jing H; Wang Y; Yu C; Wang J; Liu Z; Graviss EA; Ma X
    Int J Tuberc Lung Dis; 2012 May; 16(5):612-4. PubMed ID: 22410186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.
    Kliiman K; Altraja A
    Eur Respir J; 2009 May; 33(5):1085-94. PubMed ID: 19164345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.
    Pietersen E; Ignatius E; Streicher EM; Mastrapa B; Padanilam X; Pooran A; Badri M; Lesosky M; van Helden P; Sirgel FA; Warren R; Dheda K
    Lancet; 2014 Apr; 383(9924):1230-9. PubMed ID: 24439237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.